Early diagnostic value of soluble triggering receptor expressed on myeloid cell-1 in type 2 diabetic patients with pneumonia

Objective To investigate the early diagnostic value of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in type 2 diabetic patients with pneumonia. Methods 79 cases of type 2 diabetic patients with pneumonia between July 2008 and June 2013 were chosen as the pneumonia group. In the same period, 80 cases of type 2 diabetes mellitus patients without pneumonia were randomly selected as the control group. Levels of sTREM-1 and procalcitonin (PCT) were measured. Results The levels of sTREM-1 and PCT were significant higher in pneumonia group than those in control group (P